Medical institutions not to use recalled valsartan drug orders China
China orders medical institutions not to use recalled valsartan drug
China's health regulator has called on all medical institutions to cooperate with authorities and not use the valsartan blood and heart drug that is said to pose cancer risks.
The bulk manufacturer of the drug, Zhejiang Huahai Pharmaceutical, said earlier this month that it was recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer.
In a notice posted on its website, China's National Health and Family Planning Commission said none of the drugs recalled should be used for the diagnosis and treatment of diseases.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)